Search results
Results from the WOW.Com Content Network
Studies have come to different conclusions about the result of this disparity in spending. A 2007 review of all studies comparing health outcomes in Canada and the US in a Canadian peer-reviewed medical journal found that "health outcomes may be superior in patients cared for in Canada versus the United States, but differences are not consistent."
These include the Prix Galien Canada for outstanding academic research (2008), the Donald F. Steiner Award for Outstanding Diabetes Research from the University of Chicago (2007), the Clinical Investigator Award from the Endocrine Society (2009), the Claude Bernard Prize from the European Association for the Study of Diabetes (2012), the Oon ...
A study by the Agency for Healthcare Research and Quality (AHRQ) found that in 2010, diabetes-related ED visit rates were highest for patients aged 65 and older (1,307 per 10,000 population), compared with 45- to 64-year-olds (584 per 10,000 population) and 18- to 44-year-olds (183 per 10,000 population).
Recent reports indicate that Canada has an imbalanced supply of specialists to general physicians, and a severe shortage of family doctors, with 10 million Canadians projected to lack access to primary care, [116] [117] [118] compounded by new graduates opting against selecting family medicine, [119] and communities in rural, remote and ...
MORE: How artificial intelligence is being used to detect, treat cancer -- and the potential risks for patients. Take a recent study at Yale Medicine evaluating six "early warning systems," which ...
Today, Diabetes Canada is active in more than 150 Canadian communities and supports people living with diabetes through research, advocacy, education and services. [2] They are supported in their efforts by a community-based network of volunteers, employees, health-care professionals, researchers and partners.
Elon Musk v. RFK Jr.’s stance on Ozempic. In November, the Biden administration announced plans to provide coverage for costly anti-obesity medications, including Wegovy and Zepbound, for ...
GH therapy should begin “at the most reasonably early point in the patient's growth when they're identified to be growth hormone deficient or have idiopathic short stature,” says Khatoon.